The brain and cerebral vasculature are notoriously difficult to access – is OCT the key to the door?

Current approaches to R&D tech investment are not helping life science companies. How can the situation be improved?

A gene therapy targeting a gene that regulates antioxidant action may effectively treat retinal degeneration

Sabrina Carmichael – an experienced R&D scientist who’s “been there, done that” – helps you settle into your new home in GMP city

The red flowing through us might just be the next melanoma diagnostic tool.

There’s an unmapped world within the tumor’s microenvironment

Many drugs are applied to the eye, yet we have little to no quantitative data on ocular drug metabolism – until now…

Early detection is crucial for liver cancer patient outcomes – and a new tsRNA might be the marker we’re looking for

In regenerative medicines and therapeutics, fibroblasts can offer significant advantages over stem cells, says Hamid Khoja

Research scientist-turned-investor Alex de Winter helps you run the funding gauntlet